NASDAQ:MTEX Mannatech (MTEX) Stock Price, News & Analysis $8.40 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends About Mannatech Stock (NASDAQ:MTEX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mannatech alerts:Sign Up Key Stats Today's Range$8.40▼$8.4050-Day Range$7.05▼$8.6852-Week Range$6.75▼$10.51Volume154 shsAverage Volume3,277 shsMarket Capitalization$15.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.Read More… 917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Mannatech Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks14th Percentile Overall ScoreMTEX MarketRank™: Mannatech scored higher than 14% of companies evaluated by MarketBeat, and ranked 900th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Mannatech. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mannatech is -10.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mannatech is -10.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMannatech has a P/B Ratio of 1.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mannatech's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.19% of the float of Mannatech has been sold short.Short Interest Ratio / Days to CoverMannatech has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mannatech has recently decreased by 8.33%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldMannatech does not currently pay a dividend.Dividend GrowthMannatech does not have a long track record of dividend growth.Read more about Mannatech's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.19% of the float of Mannatech has been sold short.Short Interest Ratio / Days to CoverMannatech has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mannatech has recently decreased by 8.33%, indicating that investor sentiment is improving significantly. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Mannatech this week, compared to 0 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Mannatech insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $126,232.00 in company stock.Percentage Held by Insiders41.50% of the stock of Mannatech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 12.98% of the stock of Mannatech is held by institutions.Read more about Mannatech's insider trading history. Receive MTEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mannatech and its competitors with MarketBeat's FREE daily newsletter. Email Address MTEX Stock News HeadlinesStockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)November 18, 2024 | americanbankingnews.comMannatech Inc. Q3 Earnings SummaryNovember 13, 2024 | markets.businessinsider.comJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.November 23, 2024 | Priority Gold (Ad)Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.comNovember 13, 2024 | americanbankingnews.comMannatech Reports Financial Results for Third Quarter 2024November 12, 2024 | businesswire.comDirector Tyler Rameson Acquires 16,288 Shares of Mannatech Inc (MTEX)September 11, 2024 | finance.yahoo.comMannatech Reports Financial Results for Second Quarter 2024August 13, 2024 | finance.yahoo.comMTEX Stock Earnings: Mannatech Reported Results for Q1 2024May 15, 2024 | investorplace.comSee More Headlines MTEX Stock Analysis - Frequently Asked Questions How have MTEX shares performed this year? Mannatech's stock was trading at $8.10 at the beginning of 2024. Since then, MTEX stock has increased by 3.7% and is now trading at $8.3999. View the best growth stocks for 2024 here. How were Mannatech's earnings last quarter? Mannatech, Incorporated (NASDAQ:MTEX) issued its earnings results on Tuesday, November, 12th. The company reported ($0.17) earnings per share for the quarter. The business had revenue of $31.73 million for the quarter. Mannatech had a negative net margin of 1.26% and a negative trailing twelve-month return on equity of 15.62%. How do I buy shares of Mannatech? Shares of MTEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Mannatech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mannatech investors own include CrowdStrike (CRWD), Walt Disney (DIS), Herbalife (HLF), Roku (ROKU), Alibaba Group (BABA), Enphase Energy (ENPH) and Enterprise Products Partners (EPD). Company Calendar Last Earnings11/12/2024Today11/23/2024Fiscal Year End12/31/2024Next Earnings (Estimated)3/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MTEX CUSIPN/A CIK1056358 Webwww.mannatech.com Phone(972) 471-7400Fax972-471-8117Employees250Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,240,000.00 Net Margins-1.26% Pretax Margin-0.82% Return on Equity-15.62% Return on Assets-3.76% Debt Debt-to-Equity Ratio0.44 Current Ratio1.25 Quick Ratio0.74 Sales & Book Value Annual Sales$121.55 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value$5.30 per share Price / Book1.58Miscellaneous Outstanding Shares1,885,000Free Float1,103,000Market Cap$15.83 million OptionableNot Optionable Beta1.17 Social Links 10 Best Stocks to Own in 2025Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:MTEX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mannatech, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Mannatech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.